Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Geron Corporation (GERN)

-NasdaqGS
4.30 Down 0.03(0.69%) Apr 24, 4:00PM EDT
|After Hours : 4.38 Up 0.08 (1.86%) Apr 24, 6:55PM EDT
Add to Portfolio
Prev Close:4.33
Open:4.33
Bid:4.25 x 100
Ask:4.46 x 700
1y Target Est:5.50
Beta:2.35
Earnings Date:Apr 28 - May 4 (Est.)
Day's Range:4.30 - 4.45
52wk Range:1.60 - 4.49
Volume:3,132,906
Avg Vol (3m):3,750,790
Market Cap:678.74M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 0.69%678.74M
BMYDown 0.30%109.67B
GSKUp 0.60%112.07B
NVSDown 1.16%250.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):592.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.07
Quarterly EPS Est (Mar-15) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-12.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback